Cellectis, Wyss to engineer virus-resistant cells

Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) and George Church's lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University (Boston, Mass.) partnered to recode the entire

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE